Decibel Therapeutics

BOSTON, MA · Founded 2013 · CIK 0001656536 · Biotech · Acquired

Gene therapy for genetic hearing loss

decibeltx.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$63M
2 Form D · Nov 2020
71 months since last filing
Contracts
—
No federal contracts on record
Patents
40
12 granted · 28 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$8,000,000
Private capital raisedForm D · SEC$54,800,067
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2333NEMAGEN DISCOVERIES INC——
2334NEMAMETRIX, INC—$9.4M
2335TERAIMMUNE, INC.—$3.0M
2336Decibel Therapeutics—$63M
23373P BIOTECHNOLOGIES, INC.——
2338Mythic Therapeutics—$53M
2339DEEPSEQAI LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 16 related persons
  • Troy BrennanDirector
  • Roger BrownDirector
  • Jens EcksteinDirector
  • Neil ExterDirector
  • Steven HoltzmanDirector · Executive Officer
  • Jeffrey JonasDirector
  • John KeiltyExecutive Officer
  • Elisabeth LeidermanExecutive Officer
  • Craig MuirDirector
  • Anthony PhilippakisDirector
  • Christine PoonDirector
  • Laurence ReidDirector · Executive Officer
  • George ScangosDirector
  • Michael SolomonExecutive Officer
  • Kevin StarrDirector · Executive Officer
  • Peter ThompsonDirector

Patents

USPTO · 12 granted of 40

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.